Women with multiple sclerosis (MS) face a significantly higher risk of mental illness during and after pregnancy than those without the disease, according to a new study that analyzed data from more than 890,000 women in Canada. Mental health issues, mostly anxiety and depression, affected 42% of women…

Most treatments for multiple sclerosis (MS) don’t increase the risk of major problems when used during pregnancy, an analysis showed. “We found that most therapies were not associated with an increased risk of miscarriage, premature birth or major birth defects,” Kerstin Hellwig, MD, study co-author and MS specialist at…

Treatment with Zeposia (ozanimod) during early pregnancy may be safe for women with multiple sclerosis (MS), or inflammatory bowel diseases,  a recent study suggests. Specifically, receiving the treatment during the first trimester of pregnancy didn’t increase the incidence of fetal malformations or…

In the U.S., pregnant people with multiple sclerosis (MS) who are Black or Hispanic tend to have more severe disability than their white counterparts, along with fewer socioeconomic resources, a new study indicates.  “What we are seeing is that underrepresented women with MS start their…

Most treatments for multiple sclerosis (MS) are not associated with an increased risk of complications during pregnancy, according to a new analysis. A few therapies were associated with slightly elevated rates of congenital abnormalities for babies exposed to treatment during pregnancy, but small sample sizes limit being able to…

Roche has teamed up with researchers in Australia to study the immune and biological mechanisms leading to better outcomes for multiple sclerosis (MS) patients who are or have been pregnant. The four-year project, led by Vilija Jokubaitis, PhD, a neuroscientist and group leader at Monash University, is expected…

Women with multiple sclerosis (MS) are not at a higher risk of their babies having growth deficits during pregnancy or after birth than individuals without the disease, a study suggests. Yet, the data showed women with MS are significantly more likely to deliver their babies by cesarean section (C-section)…

Note: This story was updated on July 25, 2022, for the headline to reflect researchers gave this information in a perspective paper, not a study.  Bans on abortion and other reproductive care limitations are likely to have a profound impact on the care of people with multiple sclerosis (MS)…

Rates of sexual and emotional abuse are higher in women with multiple sclerosis (MS) compared with women in the general population, according to a new study from Norway. These women are also at more than two times higher risk of being revictimized, which occurs when a person who has…

Study: Anti-CD20 Therapies, Gilenya Lower Efficacy of COVID-19 Vaccines This research adds more evidence to studies that have already shown that certain disease-modifying therapies reduce the effectiveness of COVID-19 vaccines. Those DMTs include Kesimpta (ofatumumab) and Ocrevus (ocrelizumab), plus rituximab, another anti-CD20 vaccine, that is sometimes used…

It’s been a decade since the opening of the UK MS Register, which sought to gain a better understanding of how multiple sclerosis (MS) affects patients’ everyday lives, with a goal, according to its website, toward fueling campaigns for “fair, relevant policy and improved health care.” Now, the…

Blood Stem Cell Transplant Better than DMTs at Reducing Risk of Disease Progression in RRMS Here’s more evidence that hematopoietic stem cell transplant (HSCT) works better than some disease-modifying therapies (DMTs) at reducing multiple sclerosis (MS) progression. In this study, only three of 52 patients in the…

Many years ago a woman I know who has multiple sclerosis (MS) became pregnant. After her child was born her MS became significantly worse. There have been many studies on the impact of pregnancy on someone with MS, with most concluding that the number of MS relapses are…